Originating Organization: United States/Department of Health and Human Services

    Operation Warp Speed Therapeutics: Monoclonal Antibody Playbook Version 2.0

    This playbook is intended to support sites interested in administering COVID-19 treatment under EUA including:
    • Existing hospital or community-based infusion centers
    • Existing clinical space (e.g. urgent care, emergency depts)
    • Ad hoc new infusion sites (e.g. “hospitals without walls”)
    • Long-term care facilities or home infusions with infusion delivery capability